April 16, 2019

Moderna to Host Science Day on May 7, 2019 and Report First Quarter Financial Results on May 8, 2019

April 3, 2019

Moderna to Present at 18th Annual Needham Healthcare Conference

March 6, 2019

Moderna Reports 2018 Fourth Quarter and Full Year Financial Results and Highlights Recent Pipeline Progress

March 4, 2019

Moderna to Present at Upcoming Investor Conferences in March

February 21, 2019

Moderna to Report Fourth Quarter and Full Year 2018 Financial Results on Wednesday, March 6, 2019

February 20, 2019

Phase 1 Data Published in Nature Communications Show Potential of mRNA Encoding VEGF-A as a Regenerative Therapeutic

February 12, 2019

Moderna Announces Positive Interim Phase 1 Data for First Combination Vaccine Against the Respiratory Viruses hMPV and PIV3

February 5, 2019

Moderna Announces Dosing of the First Monoclonal Antibody Encoded by mRNA in a Clinical Trial

January 30, 2019

Newly Published Pre-Clinical Data Show Intratumoral Injections of Messenger RNA Encoding Three Immune Modulators Stimulate Durable Anti-Cancer Responses in Treated and Distal Tumors

January 18, 2019

Dr. John Mendlein to Transition to an Advisory Role at Moderna and Join Flagship Pioneering as an Executive Partner

January 8, 2019

Moderna Announces Recent Progress in Its Immuno-Oncology and Rare Disease Programs and Highlights Corporate Objectives

January 2, 2019

Moderna to Provide Business and Pipeline Updates at the 2019 J.P. Morgan Healthcare Conference